Anti-diarrhoeals Flashcards
Class of anti-diarrhoeals
OK, BB Sorry Lah:
Opioid agonist, Kaolin/Pectin, Bismuth compounds, Bile salts-binding resin, Somatostatin-like peptides, Lyophilizate of killed Lactobacillus acidophilus
Opioid agonist
Loperamide, diphenoxylate
MoA of opioid agonists
Act on ENS to increase transit time
SE of opioid agonists
Mainly CNS — addiction, abuse potential
However, loperamide does not cross BBB and is hence safer.
Diphenoxylate can cause CNS effect at higher doses and risk of dependence with LT use
How to discourage abuse of diphenoxylate
Take with atropine — cause anticholinergic effects such as dry mouth, BoV
Atropine also contribute to anti-diarrhoeal effect
Bismuth compounds
Bismuth subsalicylate, bismuth subcitrate potassium
MoA of bismuth compounds
Not exactly known, however, there is degree of anti-microbial effect (absorb enterotoxin), hence commonly used for Tx of traveller’s diarrhoea
Subsalicylate also inhibits PG production, Cl secretion –> decrease stool frequency & liquidity
SE of bismuth compounds
Generally safe profile.
Some side effects include harmless blackening of tongue, darkening of stools
Prolonged use may cause bismuth toxicity –> encephalopathy (h/a, confusion, seizures)
Salicyclate toxicity with high-dose bismuth subsalicylate
MoA of Kaolin, pectin
Absorb bacterial toxins, fluid –> decrease stool frequency, liquidity; useful in acute diarrhoea
SE of kaolin/pectin
Minimal systemic effect as not absorbed into circulation
Main issue would be constipation
Can also interfere with other drugs by binding & inhibiting them —avoid use within 2h of each other
Bile salt-binding resin
Cholestyramine
MoA of cholestyramine
Binds to bile salts –> alleviate diarrhoea caused by colonic secretory diarrhoea (e.g. Crohn’s, surgical resection –> malabsorption of bile salts –> diarrhoea)
SE of cholestyramine
Constipation, bloating, faecal impaction
Worsens fat malabsorption if already deficient
Inhibits absorption of other drugs —avoid within 2h
Somatostatin-like peptides
Somatostatin (IV), octreotide (SQ)
MoA of SLP
Inhibit release of transmitters/hormones (gastrin) –> decrease GI motility, GB, intestinal & pancreatic secretions